Effect of the administration of recombinant hirudin and/or tissue- plasminogen activator (t-PA) on endotoxin-induced disseminated intravascular coagulation model in rabbits

British Journal of Haematology

Volumn 105, Issue 1, 1999, Pages 117-121

  Munoz M C ^a   Montes, R ^a   Hermida, J ^a   Orbe, J ^a   Paramo J A ^a   Rocha, E ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

DIC; Endotoxin; Hirudin; Sepsis; T PA

Indexed keywords

ALTEPLASE; DESULFATOHIRUDIN; ENDOTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFECT; DRUG INDICATION; DRUG MIXTURE; DRUG SCREENING; FIBRIN DEPOSITION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0032917704     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1999.01298.x     Document Type: Article

References (38)

1. Abilgaard, U., Lie, M. & Ødegard, O.R. (1976) A simple amidolytic method for the determination of functionally active antithrombin III. Scandinavian Journal of Clinical and Laboratory Investigation, 36, 109-112.
2. Agnelli, G., Buchanan, M.R., Fernández, F., Boneu, B., Hirsh, J. & Collen, D. (1985) Hemorrhage-free thrombolysis by tissue plasminogen activator in rabbits: a comparison with streptokinase. Circulation, 72, 178-184.
3. Bevilacqua, M.P., Schleef, R.R., Gimbrone, M.A., Jr & Loskutoff, D.J. (1986) Regulation of the fibrinolytic system of cultured vascular endothelium by interleukin 1. Journal of Clinical Investigation, 78, 587-591.
4. Bick, R.L. (1992) Disseminated intravascular coagulation. Hematology/Oncolagy Clinics of North America, 6, 1259-1285.
5. Clauss, A. (1957) Gerinnungs physiologishe schnell Methode zur Bestimmag des Fibrinogens. Acta Haematologica, 17, 237.
6. Collen, D., Stassen, J.M. & Verstraete, M. (1983) Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis: effect of molecular form and dose of activator, age of the thrombus, and route of administration. Journal of Clinical Investigation, 71, 368-376.
7. Dickneite, G. & Czech, J. (1994) Combination of antibiotic treatment with the thrombin inhibitor recombinant hirudin for the therapy of experimental Klebsiella pneumoniae sepsis. Thrombosis and Haemostasis, 71, 768-772.
8. Dickneite, G., Czech, J. & Keuper, H. (1994) Formation of fibrinmonomers in experimental disseminated intravascular coagulation and its inhibition by recombinant hirudin. Circulating Shock, 42, 183-189.
9. Emeis, J.J., Hoekzema, R. & de Vos, A.F. (1995) Inhibiting interleukin-1 and tumor necrosis factor-α does not reduce induction of plasminogen activator inhibitor type-1 by endotoxin in rats in vivo. Blood, 85, 115-120.
10. Fenton, J.W., II (1986) Thrombin. Annals of the New York Academy of Sciences, 485, 5-15.
11. Gelerther, T.D. & Sznycer-Laszuk, R. (1986) Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells. Journal of Clinical Investigation, 77, 165-169.
12. Gómez, C., Páramo, J.A., Colucci, M. & Rocha, E. (1989) Effect of heparin and/or antithrombin III on the generation of endotoxin-induced plasminogen activator inhibitor. Thrombosis and Haemostasis, 62, 694-698.
13. Hardaway, R.M., Williams, C.H. & Sun, Y. (1996) A new approach to the treatment of experimental septic shock. Journal of Surgical Research, 61, 311-316.
14. Hermida, J., Montes, R., Páramo, J.A. & Rocha, E. (1998) Endotoxin-induced disseminated intravascular coagulation in rabbits: effect of recombinant hirudin on hemostatic parameters, fibrin deposits and mortality. Journal of Laboratory and Clinical Medicine, 131, 77-83.
15. Hoffmann, H., Sicbeck, M., Spannagl, M., Weis, M., Geiger, R., Jochum, M. & Fritz, H. (1990) Effect of recombinant hirudin, a specific inhibitor of thrombin on endotoxin-induced intravascular coagulation and acute lung injury in pigs. American Review of Respiratory Diseases, 142, 782-788.
16. Ishikawa, A., Hafter, R., Seemüller, U., Gokel, J.M. & Graeff, H. (1980) The effect of hirudin on endotoxin induced disseminated intravascular coagulation (DIC). Thrombosis Research, 19, 351-358.
17. Korninger, C., Matsuo, O., Suy, R., Stassen, J.M. & Collen, D. (1982) Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis. Journal of Clinical Investigation, 69, 573-580.
18. Krause, J. (1988) Catabolism of tissue-type plasminogen activator (t-PA), its variants, mutants and hybrids. Fibrinolysis, 2, 133-142.
19. Krishnamurti, C., Barr, C.F., Hasset, M.A., Young, G.D. & Alvin, B.M. (1987) Plasminogen activator inhibitor: a regulator of ancrod-induced fibrin deposition in rabbits. Blood, 69, 798-803.
20. Marlar, R.A., Kleiss, A.J. & Griffin, J.H. (1982) Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme. Blood, 59, 1067-1072.
21. Markward, F. (1991) Hirudin and derivates as anticoagulant agents. Thrombosis and Haemostasis, 66, 141-142.
22. Matsuo, O., Rijken, D.C. & Collen, D. (1981) Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus. Nature, 291, 590-591.
23. Paloma, M.J., Páramo, J.A. & Rocha, E. (1992) Effect of DDAVP on endotoxin-induced intravascular coagulation in rabbits. Thrombosis and Haemostasis, 68, 306-309.
24. Paloma, M.J., Páramo, J.A. & Rocha, E. (1995) Endotoxin-induced intravascular coagulation in rabbits: effect of tissue plasminogen activator vs urokinase on PAI generation, fibrin deposits and mortality. Thrombosis and Haemostasis, 74, 1578-1582.
25. Páramo, J.A., Alfaro, M.J. & Rocha, E. (1985) Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast acting inhibitor: relationship to deep vein thrombosis and influence of prophylaxis. Thrombosis and Haemostasis, 54, 713-716.
26. Páramo, J.A., Fernández, F.J. & Rocha, E. (1988) Plasminogen activator inhibitor activity in bacterial infection. Thrombosis and Haemostasis, 59, 451-454.
27. Páramo, J.A., Pérez, J.L., Serrano, M. & Rocha, E. (1990) Types 1 and 2 plasminogen activator inhibitor and tumor necrosis factor alpha in patients with sepsis. Thrombosis and Haemostasis, 64, 3-6.
28. Páramo, J.A. & Rocha, E. (1994) Nuevos conceptos sobre el papel de la hemostasia en la patyogenia y tratamiento de la sepsis. Medicina Clinica, 103, 26-29.
29. Robboy, S.J., Major, M.C., Colman, R.W. & Minna, J.D. (1972) Pathology of disseminated intravascular coagulation (DIC): analysis of 26 cases. Human Pathology, 3, 327-343.
30. Schneider, J. (1993) Fibrin-specific lysis of microthrombosis in endotoxemic rats by saruplase. Thrombosis Research, 72, 71-82.
31. Taylor, F.B., Jr. Chang, A.C.K., Peer, G.T., Mather, T., Blick, K., Catlett, R., Lockhart, M.S. & Esmon, C.T. (1991) DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage. Blood, 78, 364-368.
32. Ten-Cate, H., Nurmohamed, M.T. & Ten-Cate, J.W. (1996) Developments in antithrombotic therapy: state of the art anno 1996. Pharmacology World Science, 18, 195-203.
33. Van Hinsberg, V.W.M., Kooistra, T., Van den Berg, E.A., Princen, H.M.G., Fiers, W. & Emeis, J.J. (1988) Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood, 72, 1467-1473.
34. Verheijen, J.H., Mullaart, E., Chang, G.T.G., Kluft, C. & Wingaards, G. (1982) A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thrombosis and Haemostasis, 48, 266-269.
35. Vinazzer, H. & Pangraz, U. (1987) Protein C: comparison of different assays in normal and abnormal plasma samples. Thrombosis Research, 46, 1-8.
36. Warr, T.A., Mohan Rao, L.V. & Rapaport, S.I. (1990) Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood, 75, 1481-1489.
37. Weitz, J.I., Hudoba, M., Massel, D., Maraganore, J. & Hirsh, J. (1990) Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. Journal of Clinical Investigation, 86, 385-391.
38. Zawilska, K., Zozulinska, M., Turowiecka, Z., Blahut, M., Drobnik, L. & Vinazzer, H. (1993) The effect of a long-acting recombinant hirudin (PEG-hirudin) on experimental disseminated intravascular coagulation (DIC) in rabbits. Thrombosis Research, 69, 315-320.